DNA methylation of the promoter of soluble epoxide hydrolase silences its expression by an SP-1-dependent mechanism

Donghong Zhang, Ding Ai, Hiromasa Tanaka, Bruce D. Hammock, Yi Zhu

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Epoxyeicosatrienoic acids, derived from arachidonic acid, function as antihypertensive and antihypertrophic mediators in the cardiovascular system. They are hydrolyzed by soluble epoxide hydrolase (sEH). Pharmacological inhibition of sEH increases the level of epoxyeicosatrienoic acids, which may have a cardiovascular protective effect. However, the regulation and function of sEH in cancer are largely unknown. The present study investigated whether DNA methylation regulates the expression of sEH in carcinoma HepG2 cells. The mRNA and protein expressions of sEH in HepG2 cells were lower than those in transformed human embryonic kidney cells and in primary cultured human endothelial cells. Bioinformatic analysis revealed a putative CpG island and 5 SP-1 binding sites located in the promoter region of the sEH gene. Furthermore, the sEH expression was significantly enhanced by demethylation treatment with 5-Aza-CdR, a DNA methyltransferase inhibitor, and the sEH promoter was transformed from hypermethylation to hypomethylation as detected by methylation-specific PCR and bisulfite sequencing. Transient transfection assays showed that the activity of the human sEH promoter was increased in HepG2 cells in response to 5-Aza-CdR. Five SP-1 binding sites in the promoter region responding to treatment with 5-Aza-CdR were identified by construct deletion and mutation analysis and chromatin immunoprecipitation assay. Interestingly, adenoviral overexpression of sEH in HepG2 cells decreased cell proliferation. Thus, SP-1 is involved in the decrease in the transcription of sEH as a result of DNA methylation in HepG2 cells, which might contribute to epigenetic mechanism-induced carcinogenesis in hepatocytes.

Original languageEnglish (US)
Pages (from-to)659-667
Number of pages9
JournalBiochimica et Biophysica Acta - Gene Regulatory Mechanisms
Volume1799
Issue number9
DOIs
StatePublished - Sep 2010

Fingerprint

Epoxide Hydrolases
DNA Methylation
Hep G2 Cells
Genetic Promoter Regions
Assays
Binding Sites
Cardiovascular system
CpG Islands
Acids
Methylation
Sequence Deletion
Chromatin Immunoprecipitation
Endothelial cells
Cell proliferation
Methyltransferases
Transcription
Bioinformatics
Cardiovascular System
Computational Biology
Arachidonic Acid

Keywords

  • Hepatocyte
  • Methylation
  • SEH
  • SP-1

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Genetics
  • Molecular Biology
  • Structural Biology

Cite this

DNA methylation of the promoter of soluble epoxide hydrolase silences its expression by an SP-1-dependent mechanism. / Zhang, Donghong; Ai, Ding; Tanaka, Hiromasa; Hammock, Bruce D.; Zhu, Yi.

In: Biochimica et Biophysica Acta - Gene Regulatory Mechanisms, Vol. 1799, No. 9, 09.2010, p. 659-667.

Research output: Contribution to journalArticle

Zhang, Donghong ; Ai, Ding ; Tanaka, Hiromasa ; Hammock, Bruce D. ; Zhu, Yi. / DNA methylation of the promoter of soluble epoxide hydrolase silences its expression by an SP-1-dependent mechanism. In: Biochimica et Biophysica Acta - Gene Regulatory Mechanisms. 2010 ; Vol. 1799, No. 9. pp. 659-667.
@article{0d36840b90c8481084d668144be123c6,
title = "DNA methylation of the promoter of soluble epoxide hydrolase silences its expression by an SP-1-dependent mechanism",
abstract = "Epoxyeicosatrienoic acids, derived from arachidonic acid, function as antihypertensive and antihypertrophic mediators in the cardiovascular system. They are hydrolyzed by soluble epoxide hydrolase (sEH). Pharmacological inhibition of sEH increases the level of epoxyeicosatrienoic acids, which may have a cardiovascular protective effect. However, the regulation and function of sEH in cancer are largely unknown. The present study investigated whether DNA methylation regulates the expression of sEH in carcinoma HepG2 cells. The mRNA and protein expressions of sEH in HepG2 cells were lower than those in transformed human embryonic kidney cells and in primary cultured human endothelial cells. Bioinformatic analysis revealed a putative CpG island and 5 SP-1 binding sites located in the promoter region of the sEH gene. Furthermore, the sEH expression was significantly enhanced by demethylation treatment with 5-Aza-CdR, a DNA methyltransferase inhibitor, and the sEH promoter was transformed from hypermethylation to hypomethylation as detected by methylation-specific PCR and bisulfite sequencing. Transient transfection assays showed that the activity of the human sEH promoter was increased in HepG2 cells in response to 5-Aza-CdR. Five SP-1 binding sites in the promoter region responding to treatment with 5-Aza-CdR were identified by construct deletion and mutation analysis and chromatin immunoprecipitation assay. Interestingly, adenoviral overexpression of sEH in HepG2 cells decreased cell proliferation. Thus, SP-1 is involved in the decrease in the transcription of sEH as a result of DNA methylation in HepG2 cells, which might contribute to epigenetic mechanism-induced carcinogenesis in hepatocytes.",
keywords = "Hepatocyte, Methylation, SEH, SP-1",
author = "Donghong Zhang and Ding Ai and Hiromasa Tanaka and Hammock, {Bruce D.} and Yi Zhu",
year = "2010",
month = "9",
doi = "10.1016/j.bbagrm.2010.09.006",
language = "English (US)",
volume = "1799",
pages = "659--667",
journal = "Biochimica et Biophysica Acta - Gene Regulatory Mechanisms",
issn = "1874-9399",
publisher = "Elsevier",
number = "9",

}

TY - JOUR

T1 - DNA methylation of the promoter of soluble epoxide hydrolase silences its expression by an SP-1-dependent mechanism

AU - Zhang, Donghong

AU - Ai, Ding

AU - Tanaka, Hiromasa

AU - Hammock, Bruce D.

AU - Zhu, Yi

PY - 2010/9

Y1 - 2010/9

N2 - Epoxyeicosatrienoic acids, derived from arachidonic acid, function as antihypertensive and antihypertrophic mediators in the cardiovascular system. They are hydrolyzed by soluble epoxide hydrolase (sEH). Pharmacological inhibition of sEH increases the level of epoxyeicosatrienoic acids, which may have a cardiovascular protective effect. However, the regulation and function of sEH in cancer are largely unknown. The present study investigated whether DNA methylation regulates the expression of sEH in carcinoma HepG2 cells. The mRNA and protein expressions of sEH in HepG2 cells were lower than those in transformed human embryonic kidney cells and in primary cultured human endothelial cells. Bioinformatic analysis revealed a putative CpG island and 5 SP-1 binding sites located in the promoter region of the sEH gene. Furthermore, the sEH expression was significantly enhanced by demethylation treatment with 5-Aza-CdR, a DNA methyltransferase inhibitor, and the sEH promoter was transformed from hypermethylation to hypomethylation as detected by methylation-specific PCR and bisulfite sequencing. Transient transfection assays showed that the activity of the human sEH promoter was increased in HepG2 cells in response to 5-Aza-CdR. Five SP-1 binding sites in the promoter region responding to treatment with 5-Aza-CdR were identified by construct deletion and mutation analysis and chromatin immunoprecipitation assay. Interestingly, adenoviral overexpression of sEH in HepG2 cells decreased cell proliferation. Thus, SP-1 is involved in the decrease in the transcription of sEH as a result of DNA methylation in HepG2 cells, which might contribute to epigenetic mechanism-induced carcinogenesis in hepatocytes.

AB - Epoxyeicosatrienoic acids, derived from arachidonic acid, function as antihypertensive and antihypertrophic mediators in the cardiovascular system. They are hydrolyzed by soluble epoxide hydrolase (sEH). Pharmacological inhibition of sEH increases the level of epoxyeicosatrienoic acids, which may have a cardiovascular protective effect. However, the regulation and function of sEH in cancer are largely unknown. The present study investigated whether DNA methylation regulates the expression of sEH in carcinoma HepG2 cells. The mRNA and protein expressions of sEH in HepG2 cells were lower than those in transformed human embryonic kidney cells and in primary cultured human endothelial cells. Bioinformatic analysis revealed a putative CpG island and 5 SP-1 binding sites located in the promoter region of the sEH gene. Furthermore, the sEH expression was significantly enhanced by demethylation treatment with 5-Aza-CdR, a DNA methyltransferase inhibitor, and the sEH promoter was transformed from hypermethylation to hypomethylation as detected by methylation-specific PCR and bisulfite sequencing. Transient transfection assays showed that the activity of the human sEH promoter was increased in HepG2 cells in response to 5-Aza-CdR. Five SP-1 binding sites in the promoter region responding to treatment with 5-Aza-CdR were identified by construct deletion and mutation analysis and chromatin immunoprecipitation assay. Interestingly, adenoviral overexpression of sEH in HepG2 cells decreased cell proliferation. Thus, SP-1 is involved in the decrease in the transcription of sEH as a result of DNA methylation in HepG2 cells, which might contribute to epigenetic mechanism-induced carcinogenesis in hepatocytes.

KW - Hepatocyte

KW - Methylation

KW - SEH

KW - SP-1

UR - http://www.scopus.com/inward/record.url?scp=78149415042&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78149415042&partnerID=8YFLogxK

U2 - 10.1016/j.bbagrm.2010.09.006

DO - 10.1016/j.bbagrm.2010.09.006

M3 - Article

C2 - 20888937

AN - SCOPUS:78149415042

VL - 1799

SP - 659

EP - 667

JO - Biochimica et Biophysica Acta - Gene Regulatory Mechanisms

JF - Biochimica et Biophysica Acta - Gene Regulatory Mechanisms

SN - 1874-9399

IS - 9

ER -